Form 4: Unity Biotechnology CEO Anirvan Ghosh Sells Shares to Cover Tax Obligations

Anirvan Ghosh, CEO of Unity Biotechnology, sold 432 shares of common stock at $1.29 per share on November 4, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On November 4, 2024, Anirvan Ghosh, the CEO of Unity Biotechnology, sold 432 shares of the company's common stock.
• The shares were sold at a price of $1.29 per share.
• The sale was executed to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
• Following the transaction, Ghosh beneficially owns 75,893 shares of Unity Biotechnology, including Restricted Stock Units that vest over time from the grant date.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to a stock sale for tax purposes, which is neither particularly positive nor negative.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. The sale itself is unlikely to have a significant impact on the company's overall performance or stock valuation.

Stakeholder Impact

• The sale of shares by the CEO may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial condition.

Key Dates